CMS Plans To Issue Clinical Evidence Position Paper In August
This article was originally published in The Pink Sheet Daily
Executive Summary
The coverage process could provide an incentive for well-designed practical clinical trials, CMS Chief Medical Officer Tunis says during a Drug & Device Dialogue audio conference. The paper will describe the agency’s activities in designing clinical studies.
You may also be interested in...
Acomplia Pricing Likely To Follow Statin Model, Sanofi Says
Sanofi is considering a range of pricing options for the weight-loss/smoking cessation agent, company says; price will ultimately depend on labeling. Statin model would be appropriate if Sanofi can position the drug as long-term therapy to reduce adverse health outcomes.
Acomplia Pricing Likely To Follow Statin Model, Sanofi Says
Sanofi is considering a range of pricing options for the weight-loss/smoking cessation agent, company says; price will ultimately depend on labeling. Statin model would be appropriate if Sanofi can position the drug as long-term therapy to reduce adverse health outcomes.
CMS Considering Obesity Drug Coverage Under Medicare
The agency is "open" to considering coverage of obesity drugs in light of a recent change to its obesity policy, but seeks comment on how it can legally do so, given the prohibition of weight loss drug coverage under the Medicare Modernization Act.